StonvexLoading…
StonvexStonvexStonvexCore line items from AJG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.76B | $13.94B | $10.31B | $6.95B |
Operating Income | $1.04B | $1.87B | $1.69B | $1.34B |
Net Income | $822.00M | $1.49B | $1.34B | $1.07B |
EPS (Diluted) | $3.16 | $5.74 | $5.16 | $4.12 |
Total Assets | $78.30B | $70.67B | $79.07B | $80.12B |
Total Liabilities | $54.50B | $47.32B | $55.83B | $57.07B |
Cash & Equivalents | $1.41B | $1.40B | $1.40B | $14.30B |
Free Cash Flow OCF − CapEx | $921.00M | $1.78B | $1.07B | $378.10M |
Shares Outstanding | 256.90M | 257.00M | 256.80M | 256.40M |